- Home
- ASB vs ZLAB Comparison
ASB vs ZLAB Comparison
Compare ASB & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASB
- ZLAB
- Stock Information
- Founded
- ASB 1861
- ZLAB 2013
- Country
- ASB United States
- ZLAB China
- Employees
- ASB N/A
- ZLAB N/A
- Industry
- ASB Major Banks
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- ASB Finance
- ZLAB Health Care
- Exchange
- ASB Nasdaq
- ZLAB Nasdaq
- Market Cap
- ASB 3.4B
- ZLAB 3.6B
- IPO Year
- ASB N/A
- ZLAB 2017
- Fundamental
- Price
- ASB $25.86
- ZLAB $36.40
- Analyst Decision
- ASB Hold
- ZLAB Buy
- Analyst Count
- ASB 10
- ZLAB 5
- Target Price
- ASB $26.70
- ZLAB $54.28
- AVG Volume (30 Days)
- ASB 1.2M
- ZLAB 886.5K
- Earning Date
- ASB 07-24-2025
- ZLAB 08-05-2025
- Dividend Yield
- ASB 3.56%
- ZLAB N/A
- EPS Growth
- ASB N/A
- ZLAB N/A
- EPS
- ASB 0.83
- ZLAB N/A
- Revenue
- ASB $985,729,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- ASB $54.48
- ZLAB $44.07
- Revenue Next Year
- ASB $5.84
- ZLAB $49.13
- P/E Ratio
- ASB $31.26
- ZLAB N/A
- Revenue Growth
- ASB N/A
- ZLAB 43.72
- 52 Week Low
- ASB $18.32
- ZLAB $16.01
- 52 Week High
- ASB $28.18
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- ASB 72.33
- ZLAB 52.67
- Support Level
- ASB $24.20
- ZLAB $34.79
- Resistance Level
- ASB $24.77
- ZLAB $36.73
- Average True Range (ATR)
- ASB 0.53
- ZLAB 1.23
- MACD
- ASB 0.23
- ZLAB -0.46
- Stochastic Oscillator
- ASB 94.41
- ZLAB 25.91
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.